MedTrace Logo

In Vivo Real-time Detection of Circulating Melanoma Cells

NCT01776905 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2025-07-16

No results posted yet for this study

Summary

The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.

Conditions

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Jumin Sunde, MD · University of Arkansas

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01776905 on ClinicalTrials.gov